Sign In
Buy OMI
$2.80
+0 (+0%)
At Close: Mar 30, 2026
Here's Why You Should Hold on to Cardiovascular Systems (CSII)
02:07pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Investors are optimistic about Cardiovascular Systems' (CSII) robust international growth and upcoming launches.
IDEXX (IDXX) CAG Sales Gain Traction, FX Headwind Persists
02:46pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.
Here's Why You Should Retain Boston Scientific (BSX) For Now
02:42pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Investors are optimistic about Boston Scientific's (BSX) robust organic sales and strategic buyouts.
Here's Why You Should Retain Thermo Fisher (TMO) For Now
02:01pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Investors are optimistic about Thermo Fisher's (TMO) better-than-expected fourth-quarter results and impressive COVID-19 response-related revenues.
Charles River (CRL) Buys Explora BioLabs to Expand in CRO Space
03:48pm, Monday, 11'th Apr 2022 Zacks Investment Research
Explora BioLabs' business is likely to complement and expand the Charles River's (CRL) CRADL operation within the broader Insourcing Solutions business.
Alcon's (ALC) Surgical Arm Rebounds, New Launches Aid Growth
02:37pm, Monday, 11'th Apr 2022 Zacks Investment Research
In Vision Care, Alcon (ALC) continues to see strong demand for PRECISION1 and PRECISION1 for Astigmatism, which are the company's newest contact lenses for the mainstream market.
STERIS (STE) Up 8% Since Q3 Earnings: What's Driving It?
02:18pm, Monday, 11'th Apr 2022 Zacks Investment Research
Investors are optimistic about STERIS' (STE) robust segmental growth and noteworthy acquisitions in the healthcare and pharmaceutical spaces.
Here's Why You Should Retain Charles River (CRL) Stock For Now
12:54pm, Monday, 11'th Apr 2022 Zacks Investment Research
Investors are optimistic about Charles River's (CRL) strong segmental growth and notable partnerships.
Here's Why You Should Retain Amedisys (AMED) Stock For Now
02:11pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Investors are optimistic about Amedisys' (AMED) strong segmental performance and strategic buyouts.
Thermo Fisher (TMO) Debuts Raman Spectroscopic Analyzer
01:35pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Thermo Fisher's (TMO) Ramina Process Analyzer allows users to conduct precise in situ Raman measurements in a simple manner with high accuracy.
Here's Why You Should Retain Teleflex (TFX) Stock for Now
02:05pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Investors are optimistic about Teleflex (TFX) on increased UroLift demand and strong vascular business.
Medtronic (MDT) Reports Positive Findings Backing RDN System
01:30pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Medtronic's (MDT) Symplicity Spyral RDN system demonstrated durable and clinically significant reductions in blood pressure at the SPYRAL HTN-ON MED trial.
Here's Why Owens & Minor (OMI) Looks Ripe for Bottom Fishing
02:16pm, Monday, 04'th Apr 2022 Zacks Investment Research
Owens & Minor (OMI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean
AMN Healthcare (AMN) Stock Moves Up 12.9%: What's Driving It?
01:51pm, Monday, 04'th Apr 2022 Zacks Investment Research
Investors are optimistic about AMN Healthcare's (AMN) strong segmental performance and upbeat first-quarter guidance.
Quipt Convertible Debenture Hedging Provides An Incredible Opportunity
02:55am, Monday, 04'th Apr 2022
Quipt Convertible Debenture Hedging Provides An Incredible Opportunity
